Issued 2026-09-16 at $4.09 · now $4.09 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, ESRT has typically landed between $3.50 and $4.68 — a range of −14.5% to +14.3% from the issuance price $4.09.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
3,237 overlapping 1 month windows · 2013-10-02 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($4.09) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where ESRT has typically landed a month from the 2026-09-16 close of $4.09 — the range is history, not a prediction.
- now $4.09 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $4.03 (-1.5%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $3.76–$4.3
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $3.5–$4.68
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2020-02-18 | −45.8% | −45.8% | +1.0% |
| 2020-02-21 | −43.5% | −45.4% | +0.0% |
| 2020-02-20 | −41.6% | −46.4% | +0.0% |
| 3 best | |||
| 2020-11-04 | +82.8% | −0.8% | +82.8% |
| 2020-10-28 | +77.6% | −1.6% | +80.6% |
| 2020-11-06 | +74.7% | +0.0% | +84.2% |
3,237 overlapping windows · 2013-10-02 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~13 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-24 | Durels Thomas P. | officer | Sale | 11,843 @ $8.02 | $95K | −21.1% of holding | −4.0% | −20.9% | 44,185 | Form 4 · filed 1 day after the trade |
| 2025-03-21 | Durels Thomas P. | officer | Sale | 5,779 @ $8.03 | $46K | −9.4% of holding | −4.0% | −24.6% | 56,028 | Form 4 · filed 4 days after the trade |
| 2025-03-20 | Durels Thomas P. | officer | Sale | 12,500 @ $8.15 | $102K | −16.8% of holding | −5.4% | −27.0% | 61,807 | Form 4 · filed 1 day after the trade |
| 2025-03-19 | Durels Thomas P. | officer | Sale | 12,500 @ $8.11 | $101K | −14.4% of holding | −5.1% | −21.8% | 74,307 | Form 4 · filed 2 days after the trade |
| 2024-12-24 | Durels Thomas P. | officer | Sale | 10,000 @ $10.10 | $101K | −10.3% of holding | −7.7% | −22.6% | 86,807 | Form 4 · filed 3 days after the trade |
| 2024-12-18 | Durels Thomas P. | officer | Sale | 3,193 @ $10.90 | $35K | −3.2% of holding | −9.8% | −24.3% | 96,807 | Form 4 · filed 1 day after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
49 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-05-15 | GILBERT STEVEN J | director | Award / grant | 23,856 | 227,721 | Form 4 |
| 2026-05-15 | GILBERT STEVEN J | director | Award / grant | 19,236 | 246,957 | Form 4 |
| 2026-05-15 | Hood Robert Paige | director | Award / grant | 23,856 | 193,541 | Form 4 |
| 2026-05-15 | Hood Robert Paige | director | Award / grant | 19,236 | 212,777 | Form 4 |
| 2026-05-15 | Hill Grant | director | Award / grant | 23,856 | 173,692 | Form 4 |
| 2026-05-15 | Hill Grant | director | Award / grant | 19,236 | 192,928 | Form 4 |
| 2026-05-15 | Robinson James D IV | director | Award / grant | 23,856 | 246,485 | Form 4 |
| 2026-05-15 | Robinson James D IV | director | Award / grant | 19,236 | 265,721 | Form 4 |
| 2026-05-15 | YANG HANNAH Y | director | Award / grant | 23,856 | 67,248 | Form 4 |
| 2026-05-15 | Giliberto Salvatore Michael | director | Award / grant | 23,856 | 172,306 | Form 4 |
| 2026-05-15 | Giliberto Salvatore Michael | director | Award / grant | 19,236 | 191,542 | Form 4 |
| 2026-05-15 | HAN PATRICIA | director | Award / grant | 23,856 | 149,979 | Form 4 |
| 2026-05-15 | Van Tassell Christina | director | Award / grant | 23,856 | 67,248 | Form 4 |
| 2026-05-15 | Malkin George L.W. | director | Award / grant | 23,856 | 38,071 | Form 4 |
| 2026-03-13 | Horn Stephen | officer | Award / grant | 69,988 | 224,690 | Form 4 |
| 2026-03-13 | MALKIN ANTHONY E | director | Award / grant | 601,384 | 6,961,958 | Form 4 |
| 2026-03-13 | MALKIN ANTHONY E | director | Award / grant | 599,133 | 7,561,091 | Form 4 |
| 2026-03-13 | Durels Thomas P. | officer | Award / grant | 321,670 | 1,900,494 | Form 4 |
| 2026-03-13 | Chiu Christina | officer | Award / grant | 261,808 | 1,759,022 | Form 4 |
| 2026-03-13 | Sutherland Donna Jean | officer | Award / grant | 11,584 | 17,836 | Form 4 |
| 2026-02-03 | Durels Thomas P. | officer | Award / grant | 263,831 | 3,211,106 | Form 4 |
| 2026-02-03 | MALKIN ANTHONY E | director | Award / grant | 499,603 | 6,360,574 | Form 4 |
| 2026-02-03 | Chiu Christina | officer | Award / grant | 196,957 | 1,497,214 | Form 4 |
| 2026-02-03 | Horn Stephen | officer | Award / grant | 16,027 | 154,702 | Form 4 |
| 2025-07-17 | Malkin George L.W. | director | Award / grant | 14,215 | 14,215 | Form 4 |
| 2025-05-16 | Robinson James D IV | director | Award / grant | 13,352 | 222,629 | Form 4 |
| 2025-05-16 | Hill Grant | director | Award / grant | 16,484 | 136,484 | Form 4 |
| 2025-05-16 | Hill Grant | director | Award / grant | 13,352 | 149,836 | Form 4 |
| 2025-05-16 | Hood Robert Paige | director | Award / grant | 16,484 | 156,333 | Form 4 |
| 2025-05-16 | Hood Robert Paige | director | Award / grant | 13,352 | 169,685 | Form 4 |
| 2025-05-16 | GILBERT STEVEN J | director | Award / grant | 16,484 | 190,513 | Form 4 |
| 2025-05-16 | GILBERT STEVEN J | director | Award / grant | 13,352 | 203,865 | Form 4 |
| 2025-05-16 | Giliberto Salvatore Michael | director | Award / grant | 16,484 | 148,450 | Form 4 |
| 2025-05-16 | Robinson James D IV | director | Award / grant | 16,484 | 209,277 | Form 4 |
| 2025-05-16 | HAN PATRICIA | director | Award / grant | 16,484 | 126,123 | Form 4 |
| 2025-05-16 | Van Tassell Christina | director | Award / grant | 16,484 | 43,392 | Form 4 |
| 2025-05-16 | YANG HANNAH Y | director | Award / grant | 16,484 | 43,392 | Form 4 |
| 2025-03-13 | Durels Thomas P. | officer | Award / grant | 200,547 | 2,947,275 | Form 4 |
| 2025-03-13 | Chiu Christina | officer | Award / grant | 169,084 | 1,300,257 | Form 4 |
| 2025-03-13 | Horn Stephen | officer | Award / grant | 43,528 | 138,675 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.